Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
Chengdu Easton Biopharmaceuticals Co Ltd
Inventory
Chengdu Easton Biopharmaceuticals Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
Inventory
¥190m
|
CAGR 3-Years
22%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Inventory
¥653.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Inventory
¥2.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Inventory
¥5.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
0%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Inventory
¥4.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Inventory
¥162.2m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Chengdu Easton Biopharmaceuticals Co Ltd
Glance View
Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of chemical raw materials and chemical drug preparations. The company is headquartered in Chengdu, Sichuan and currently employs 1,188 full-time employees. The company went IPO on 2020-09-02. The firm's main products are chemical generic drugs. Its products include nalmefene hydrochloride injection, caffeine citrate injection, ibuprofen injection, bisoprolol fumarate tablets, ubenimex, etc. Its products are used in the fields of anesthesia and analgesia, cardiovascular, anti-tumor, digestion and children's medicine. The firm operates its businesses within the China market and to overseas markets such as Russia, Switzerland, Tunisia, Germany, South Korea and Japan.
See Also
What is Chengdu Easton Biopharmaceuticals Co Ltd's Inventory?
Inventory
190m
CNY
Based on the financial report for Dec 31, 2024, Chengdu Easton Biopharmaceuticals Co Ltd's Inventory amounts to 190m CNY.
What is Chengdu Easton Biopharmaceuticals Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
26%
Over the last year, the Inventory growth was 18%. The average annual Inventory growth rates for Chengdu Easton Biopharmaceuticals Co Ltd have been 22% over the past three years , 26% over the past five years .
